US Patent 9821031 Methods and compositions for treating hypoglycemic disorders
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+292 characters)
Article
Patent abstract
This invention relates to methods of treating and ameliorating congenital and neonatal hyperinsulinism and post-prandial hypoglycemia, comprising the step of administering an antagonist of the Glucagon-Like Peptide-1 (GLP-I) receptor, e.g. a GLP-I fragment or analogue thereof.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Charles Stanley0
Diva D. De Leon0
Doris Stoffers0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09821031 Methods and compositions for treating hypoglycemic disorders US Patent 9821031 Methods and compositions for treating hypoglycemic disorders
Infobox
Patent Number
098210310
Patent Number
98210310
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
098210310
Date of Patent
November 21, 2017
0Patent Application Number
125222740
Date Filed
January 8, 2008
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09821031 Methods and compositions for treating hypoglycemic disorders
Infobox
Is a
Patent jurisdiction
Patent number
09821031
Date of patent
November 21, 2017
Patent application number
12522274
Date Filed
January 8, 2008
Patent primary examiner
Find more entities like US Patent 9821031 Methods and compositions for treating hypoglycemic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
